Strattera

atomoxetine

Straterra is given to children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The U.S. Food and Drug Administration issued an advisory to health officials in December 2004 warning that severe liver injury may lead to liver failure resulting in death or the need for a liver transplant. The label also mentions that the number of actual cases of severe liver injury may be higher than previously thought, due to under-reporting. The warning states that patients taking the medication who develop jaundice (yellowing of the skin or whites of the eyes) should stop taking Strattera.

* Strattera* is one of the many ADHD drugs linked to an increased risk of cardiovascular events in both children and adults, including heart attacks, heart failures, strokes, and sudden cardiac deaths. Children on ADHD drugs also may be at an increased risk for psychiatric adverse events usch as hallucinations, manic episodes, hearing voices, or becoming overly suspicious or paranoid.